Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia

Journal of Clinical Oncology

Volumn 20, Issue 10, 2002, Pages 2480-2485

  Fröhling, Stefan ^a   Skelin, Silvia ^a   Liebisch, Claudia ^a   Scholl, Claudia ^a   Schlenk, Richard F ^a   Döhner, Hartmut ^a   Döhner, Konstanze ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 8; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; METAPHASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY;

ACUTE DISEASE; ADOLESCENT; ADULT; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES; CYTOGENETICS; DNA PROBES; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID; MIDDLE AGED; MOLECULAR BIOLOGY; PROSPECTIVE STUDIES; TRANSLOCATION, GENETIC;

EID: 0037093105     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.08.155     Document Type: Article

References (23)

1. Clinical importance of cytogenetics in acute myeloid leukaemia
2. Clinical significance of cytogenetics in acute myeloid leukemia
3. The role of chromosome translocations in leukemogenesis
4. Molecular evaluation of acute myeloid leukemia
5. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subgroup
6. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1612 patients entered into the MRC AML10 trial
7. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group study
8. Fluorescence in situ hybridization: Uses and limitations
9. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia
10. Proposed revised criteria of the classification of acute myeloid leukemia
11. Stratification of postremission therapy in adult acute myeloid leukemia according to the karyotype: First results of the AML HD93 multicenter treatment trial
12. Selection of a human chromosome 21 enriched YAC sub-library using a chromosomespecific composite probe
13. Metaphase and interphase cytogenetics with Alu-PCR-amplified yeast artificial chromosome clones containing the BCR gene and the protooncogenes c-raf-1, c-fins, and c-erbB- 2
14. A method for the rapid sequence-independent amplification of microdissected chromosome material
15. Randomised comparison of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial
16. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv (16) in a prospective series of adults with de novo acute myeloid leukemia: A Cancer and Leukemia Group B study
17. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): Results of the European Working Party
18. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia
19. Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B study
20. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics
21. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
22. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha) in acute myeloid leukemia